Literature DB >> 18442910

Potent and orally bioavailable zwitterion GnRH antagonists with low CYP3A4 inhibitory activity.

Chen Chen1, Yongsheng Chen, Joseph Pontillo, Zhiqiang Guo, Charles Q Huang, Dongpei Wu, Ajay Madan, Takung Chen, Jenny Wen, Qiu Xie, Fabio C Tucci, Martin Rowbottom, Yun-Fei Zhu, Warren Wade, John Saunders, Haig Bozigian, R Scott Struthers.   

Abstract

Incorporation of a carboxylic acid into a series of uracil derivatives as hGnRH-R antagonists resulted in a significant reduction of CYP3A4 inhibitory activity. Highly potent hGnRH antagonists with low CYP3A4 inhibitory liability, such as 8a and 8d, were identified. Thus, 8a had a K(i) of 2.2 nM at GnRH-R and an IC(50) of 36 microM at CYP3A4.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18442910     DOI: 10.1016/j.bmcl.2008.04.036

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Synthesis and crystal structure of new heterocyles derived from saccharin and uracil carrying 1,2,4-oxadiazolylmethyl group.

Authors:  Yaşar Dürüst; Besra Özer; Benson M Kariuki; Benson M Cariuki
Journal:  Mol Divers       Date:  2015-03-10       Impact factor: 2.943

Review 2.  Recent Development of Non-Peptide GnRH Antagonists.

Authors:  Feng-Ling Tukun; Dag Erlend Olberg; Patrick J Riss; Ira Haraldsen; Anita Kaass; Jo Klaveness
Journal:  Molecules       Date:  2017-12-09       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.